Biotech/Healthcare are certainly seeing inflows of money from institutions. The RS on this name along with the clear volume accumulation is really nice. Potential consolidation into ATH Breakout.
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。